Live feed
Filing
SC 13D
SC 13D0000908834-24-000173·Akari Therapeutics Plc
Schedule 13D ownership disclosure
AKARI THERAPEUTICS PLC
Security class unavailable · CUSIP: 00972G207
Event date: 2024-05-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,370,750,000
- Percent of class
- 9.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000908834-24-000173
- Form type
- SC 13D
- Filer
- Akari Therapeutics Plc
- CIK
- CIK 1541157
- Filed
- Jun 18, 2024
- Reporting period
- May 31, 2024
- Description
- Schedule 13D beneficial ownership